Genetic overlap between treatment-resistant schizophrenia and smoking initiation

Area of Science:

• Psychiatric Genetics
• Schizophrenia Research
• Behavioral Genetics

Background:

• Treatment-resistant schizophrenia (TRS) is a heritable condition, but its genetic basis remains largely unknown.
• Cigarette smoking is linked to poorer antipsychotic response in schizophrenia and shares genetic underpinnings with the disorder.
• Investigating shared genetic factors may illuminate the biology of TRS.

Purpose of the Study:

• To identify genetic variants associated with treatment-resistant schizophrenia (TRS).
• To increase statistical power for detecting TRS-associated variants by leveraging genetic overlap with smoking initiation.
• To explore the biological mechanisms underlying TRS and its treatment response.

Main Methods:

• Genome-wide association studies (GWAS) for TRS and smoking initiation.
• Conditional/conjunctional false discovery rate (cond/conjFDR) to identify shared genetic loci.
• LD score regression for genetic correlation analysis and Mendelian randomization (MR) for causal inference.
• Functional analysis of shared loci and drug target gene enrichment.

Main Results:

• A significant positive genetic correlation (rg = 0.47, p = 0.0002) was observed between TRS and smoking initiation.
• Four novel genetic loci jointly associated with TRS and smoking initiation were identified.
• Polygenic prediction of TRS was improved using condFDR results.
• Mendelian randomization suggested a potential causal effect of genetic liability for TRS on smoking initiation.
• Functional analyses implicated alpha-1-adrenergic receptors in TRS pathophysiology and clozapine efficacy.

Conclusions:

• Shared genetic mechanisms contribute to both treatment-resistant schizophrenia (TRS) and smoking behavior.
• These findings provide novel insights into the biological underpinnings of TRS.
• The identified genetic loci and pathways may inform future therapeutic strategies for TRS.